This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Anna Polyakova-Akkus: Innovator in Pharmaceutical Science
Introduction
Anna Polyakova-Akkus is a notable inventor based in West Lafayette, IN (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of novel co-crystal forms of compounds that can aid in the prevention of arterial thrombotic complications.
Latest Patents
Anna holds 1 patent for her invention titled "Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitor." This invention relates to innovative co-crystal forms of a specific compound, where the co-former molecule can be selected from various acids, including glycolic acid and salicylic acid. The patent also covers processes for preparing these co-crystals, their pharmaceutical compositions, and their therapeutic applications in treating diseases related to coronary artery, cerebrovascular, or peripheral vascular conditions.
Career Highlights
Anna is currently associated with AstraZeneca AB, where she continues to advance her research and development efforts. Her work focuses on creating effective medicinal solutions that can significantly improve patient outcomes in cardiovascular health.
Collaborations
Anna has collaborated with esteemed colleagues such as Stephen David Cosgrove and Valeriya N Smolenskaya, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Anna Polyakova-Akkus exemplifies the spirit of innovation in the pharmaceutical industry. Her work on co-crystals has the potential to make a meaningful impact on the treatment of serious health conditions.